Growth Metrics

Insulet (PODD) Operating Income Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 37.50%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 37.50%
Dec 31, 2025 33.85%
Sep 30, 2025 33.60%
Jun 30, 2025 122.20%
Mar 31, 2025 56.06%
Dec 31, 2024 2.63%
Sep 30, 2024 60.77%
Jun 30, 2024 75.24%
Mar 31, 2024 105.42%
Dec 31, 2023 353.19%
Sep 30, 2023 1,789.66%
Jun 30, 2023 216.48%
Mar 31, 2023 -26.91%
Dec 31, 2022 -52.72%
Sep 30, 2022 -91.39%
Jun 30, 2022 -201.52%
Mar 31, 2022 132.52%
Dec 31, 2021 780.82%
Sep 30, 2021 41.60%
Jun 30, 2021 -4.36%
Mar 31, 2021 117.33%
Dec 31, 2020 -140.33%
Sep 30, 2020 40.00%
Jun 30, 2020 261.84%
Mar 31, 2020 2.74%
Dec 31, 2019 11.50%
Sep 30, 2019 147.63%
Jun 30, 2019 75.72%
Dec 31, 2018 2,213.67%
Sep 30, 2018 235.37%
Jun 30, 2018 228.80%
Dec 31, 2017 81.43%
Sep 30, 2017 -15.34%
Jun 30, 2017 -160.71%
Mar 31, 2017 31.06%
Dec 31, 2016 67.23%
Sep 30, 2016 116.34%
Jun 30, 2016 90.84%
Mar 31, 2016 -5.96%
Dec 31, 2015 -1,180.22%
Sep 30, 2015 -414.39%
Jun 30, 2015 -166.27%
Mar 31, 2015 -285.26%
Dec 31, 2014 466.99%
Sep 30, 2014 83.39%
Jun 30, 2014 9.31%
Mar 31, 2014 69.61%
Dec 31, 2013 103.38%
Sep 30, 2013 -104.38%
Jun 30, 2013 44.65%
Mar 31, 2013 43.04%
Dec 31, 2012 42.10%
Sep 30, 2012 13.28%
Jun 30, 2012 29.47%
Mar 31, 2012 -49.80%
Dec 31, 2011 -8.09%
Sep 30, 2011 -18.00%
Jun 30, 2011 -50.66%